| Eligibility |
Inclusion Criteria:
- Participant provision of a signed and dated informed consent document indicating that
the participant has been informed of all pertinent aspects of the study before any
assessment is performed.
- Participant is male or female who, at the time of screening, is aged 18-65 years,
inclusive.
- Participant who is willing and able to comply with scheduled visits, sampling
schedule, treatment plan and other study procedures.
- Participant, in the opinion of the investigator or medically qualified designee, in
good general and mental health.
At Screening (Visit 1):
- Participant with at least 20 natural, permanent teeth (excluding 3rd molars).
- Participant with at least 40 evaluable surfaces.
- Overall mean Turesky Modified Quigley and Hein Plaque Index (TPI) score greater than
or equal to (>=) 1.5.
- Participants with 10% less than (<) bleeding sites (BS) < 30%
Exclusion Criteria:
- A participant who is an employee of the investigational site, either directly involved
in the conduct of the study or otherwise supervised by the investigator, or a member
of their immediate family; or a sponsor employee directly involved in the conduct of
the study or a member of their immediate family.
- A participant who has participated in other studies (including non-medicinal studies)
involving investigational product(s) in the 30 days prior to study entry and/or who is
participating in other studies during study participation.
- A participant with, in the opinion of the investigator or medically qualified
designee, an acute or chronic medical or psychiatric condition or laboratory
abnormality that may increase the risk associated with study participation or
investigational product administration or may interfere with the interpretation of
study results and, in the judgment of the investigator or medically qualified
designee, would make the participant inappropriate for entry into this study.
- A participant with any medical/oral condition which, in the opinion of the
investigator or medically qualified designee, could impact study outcomes (for
example, oral dryness or could directly influence gingival bleeding).
- A participant taking daily doses of medication/having daily treatments which, in the
opinion of the investigator or medically qualified designee, could impact study
outcomes (for example, is causing oral dryness).
- A participant who is pregnant (self-reported; no pregnancy test required) or intending
to become pregnant over the course of the study.
- A participant who is breastfeeding.
- A participant with known or suspected intolerance or hypersensitivity to the study
materials (or closely related compounds) or any of their stated ingredients.
- A participant who is unwilling or unable to comply with the Lifestyle Considerations
described in this protocol.
- A participant who has difficulty complying with study procedures and examinations,
such as excessive gagging during oral assessments.
- A participant who has had routine dental prophylaxis within 12 weeks of Screening.
- A participant who has undergone a tooth bleaching procedure (at-home or professional)
within 8 weeks of Screening.
- A participant with any of the following which, in the opinion of the investigator or
medically qualified designee, could impact study outcomes or the oral health of the
participants if they were to participate in the study:
1. Severe gingivitis.
2. Signs of active periodontal disease or who is receiving or has received treatment
for periodontal disease (including surgery) within 12 months of Screening.
3. Active caries.
4. Evidence of gross intra-oral neglect or the need for extensive dental therapy.
5. Restorations in a poor state of repair or metal fillings.
6. Any dental condition (example, malalignment, overcrowding)
7. High levels of extrinsic dental stain or calculus deposits.
- A participant with the following:
1. A tongue or lip piercing.
2. Multiple dental implants which, in the opinion of the investigator or medically
qualified designee, could impact study outcomes.
3. Fixed bridge(s) or removable partial dentures.
4. Has or has had fixed or removable orthodontic braces/bands or a fixed orthodontic
retainer within 3 months of Screening.
- A participant who is unwilling to forgo use of an orthodontic retainer for the
duration of the study, provided there would be no impact on the outcome of any
previous, completed orthodontic treatment or the participant's well-being.
- Participant who is a current smoker or an ex-smoker who stopped within 6 months of
Screening (Visit 1).
- Participant who is a currently user of recreational drugs (example, cannabis) within 6
months of Screening.
- Participant who currently uses smokeless forms of tobacco (example, chewing tobacco,
nicotine-based e-cigarettes) within 6 months of Screening.
- Visit 1 (Screening)
1. A participant who has taken antibiotics within 4 weeks of Screening.
2. Participant who has used an anti-bacterial mouthwash (example, chlorhexidine) or
another oral care product within 2 weeks of Screening that, in the opinion of the
investigator or dentally qualified designee, could affect plaque formation or
gingival health.
- Visit 2 (Baseline)
1. A participant who has taken antibiotics during the lead-in period (between
Screening and Baseline).
- Participant with a recent history (within the last year) of alcohol or other substance
abuse.
- A participant who has previously been enrolled in this study.
- Participant who, in the opinion of the investigator or medically qualified designee,
should not participate in the study.
|
